| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Course of Advanced Therapeutics, Field of Oncology, Department of Surgical Oncology and Digestive Surgery, Kagoshima University Graduate School of Medicine and Dental Sciences, 8-35-1 Sakuragaoka Kagoshima, 890-8520, Japan
Correspondence: Address correspondence and reprint requests to: Fumitake Kubo, MD; E-mail: f-kubo{at}m3.kufm.kagoshima-u.ac.jp.
Background: Angiogenic factor seems necessary for the development of hepatocellular carcinoma (HCC), which is a hypervascular malignancy. This study examined the expression of interleukin (IL)-8, a potent angiogenic factor, in HCC samples.
Methods: We measured IL8 expression by using reverse transcriptase-polymerase chain reaction in clinical HCC tissues from 45 patients who underwent surgical resection. We then assessed correlations between IL8 expression and microvessel growth or clinicopathologic factors. We also elucidated the in vitro effect of IL8 on HepG2 development by using fluorometric assays of proliferation, chemotaxis, and invasion.
Results: The expression of IL8 did not significantly correlate with the microvessel count in HCC tissues, but the incidence of microscopic vessel invasion was significantly higher in IL8positive than in IL8negative tissues. Thus, more IL8 was expressed in HCCs at pathologic stage III/IV than in those at stage I/II. Assays in vitro showed that IL8 stimulates HepG2 chemotactic and invasive activities rather than cell proliferation.
Conclusions: The expression of IL8 in human HCC has more relevance to metastatic potential, such as vessel invasion, than to angiogenesis or cell proliferation.
Key Words: Interleukin 8 Hepatocellular carcinoma Tumor progression Angiogenesis Chemotaxis Vessel invasion
This article has been cited by other articles:
![]() |
C. Rolny, L. Capparuccia, A. Casazza, M. Mazzone, A. Vallario, A. Cignetti, E. Medico, P. Carmeliet, P. M. Comoglio, and L. Tamagnone The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment J. Exp. Med., May 12, 2008; 205(5): 1155 - 1171. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |